BNN Bloomberg
🏢 Bell Media
Jun 1, 2026
· 1 min read
Quick Score
○ Unverifiable
View full audit trail →
Apotex looking to sell about $1 billion in shares in initial public offering - BNN Bloomberg
Original article ↗B.I.A.S. ANALYSIS
CENTER
LEFTCENTERRIGHT
Signal breakdown
Heuristic (v1/v3)
0.00 · CENTER
ML v2 (DistilBERT)
0.000 · CENTER
Ensemble
0.000 · CENTER
🏦 Source Intelligence
Rolling outlet bias
CENTER
avg -0.031
3,173 articles tracked
7-day bias trend
LcenterR
V.E.R.I.F.Y. has fact-checked this article.
Subscribe to see claim-by-claim verdicts and reasoning.
Subscribe to see claim-by-claim verdicts and reasoning.
Article Excerpt
TORONTO — Drug company Apotex Health Corp. says it is looking to sell about $1 billion worth of shares in its initial public offering.
The company says it expects to sell between 41.7 million and 50 million shares at a price between $20 and $24 per share.
The plan includes the sale of between 35.4 million and 42.5 million shares in a treasury offering by the company valued at a total of about $850 million.
It also includes a secondary offering of between 6.25 million and 7.5 million shares by certain shareholders valued at a total of about $150 million.
The selling shareholders are also ex…
Read full article at BNN Bloomberg ↗
How we scored this article
WTF uses a two-tier system: every article gets a heuristic bias score from keyword analysis, and priority articles (high overlap across 3+ outlets or strong heuristic signal) get full LLM analysis from B.I.A.S. and V.E.R.I.F.Y.